Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.92 Average Price Target from Analysts

Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen research firms that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, eleven have issued a buy recommendation and one has issued a strong buy recommendation on […]

Leave a Reply

Your email address will not be published.

Previous post Evercore ISI Trims KeyCorp (NYSE:KEY) Target Price to $16.50
Next post Chardan Capital Reiterates “Buy” Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)